{"nct_id":"NCT04478266","title":"Amcenestrant (SAR439859) Plus Palbociclib as First Line Therapy for Patients With ER (+) HER2(-) Advanced Breast Cancer","status":"TERMINATED","status_verified_date":"2025-09","start_date":"2020-10-14","start_date_type":"ACTUAL","primary_completion_date":"2022-06-28","primary_completion_date_type":"ACTUAL","completion_date":"2023-05-26","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}